Quick Answer
Century Therapeutics, Inc. reported Operating Income of -$17.27 million for fiscal year 2025.
Century Therapeutics, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$17.27M | +87.5% |
| 2024 | -$138.14M | +5.7% |
| 2023 | -$146.55M | -9.5% |
| 2022 | -$133.83M | -41.0% |
| 2021 | -$94.88M | -76.0% |
| 2020 | -$53.90M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$36.12M | -3.8% | -4.2% |
| June 30, 2025 | -$34.66M | +0.3% | -146.7% |
| March 31, 2025 | $74.18M | +336.9% | +313.2% |
| September 30, 2024 | -$34.79M | +2.3% | -0.1% |
| June 30, 2024 | -$34.76M | +0.9% | -11.0% |
| March 31, 2024 | -$31.31M | +2.4% | +12.1% |
| September 30, 2023 | -$35.63M | -12.3% | -1.6% |
| June 30, 2023 | -$35.08M | -11.9% | -9.3% |
- Century Therapeutics, Inc. showed an increase of +87.5% in Operating Income compared to the prior fiscal year.
- Over the 2020–2025 period, Century Therapeutics, Inc.’s operating income has grown by 68.0% (from -$53.90 million to -$17.27 million).
- The most recent figure is from Century Therapeutics, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: